PURPOSE: The purpose of this work was to compare the use of MRI and [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in the diagnosis of focal cortical dysplasia (FCD). METHOD: Nineteen patients with surgically proven FCD were analyzed retrospectively. MRI was performed in all patients, and FDG-PET was performed in 17 patients. We compared the MR and FDG-PET findings of FCD according to the histologic findings that were classified into three grades. RESULTS: Four cases were classified as Grade I, 4 cases as Grade II, and 11 cases as Grade III FCD. The lesions were detected on MRI in 9 (82%) of the 11 patients with Grade III FCD and in only 1 (13%) of the 8 patients with Grade I and II FCD. Cortical hypometabolism of the lesion was revealed on FDG-PET in 6 (86%) of the 7 patients with Grade I and II FCD and in 9 (90%) of the 10 patients with Grade III FCD. The extent of the cortical abnormality was larger on FDG-PET than on MRI in 11 (65%) of the 17 patients. CONCLUSION: FDG-PET is more useful in delineating the cortical abnormality in patients with mild degrees of FCD. The extent of the lesion was larger or similar on FDG-PET compared with that of the MRI.
PURPOSE: The purpose of this work was to compare the use of MRI and [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in the diagnosis of focal cortical dysplasia (FCD). METHOD: Nineteen patients with surgically proven FCD were analyzed retrospectively. MRI was performed in all patients, and FDG-PET was performed in 17 patients. We compared the MR and FDG-PET findings of FCD according to the histologic findings that were classified into three grades. RESULTS: Four cases were classified as Grade I, 4 cases as Grade II, and 11 cases as Grade III FCD. The lesions were detected on MRI in 9 (82%) of the 11 patients with Grade III FCD and in only 1 (13%) of the 8 patients with Grade I and II FCD. Cortical hypometabolism of the lesion was revealed on FDG-PET in 6 (86%) of the 7 patients with Grade I and II FCD and in 9 (90%) of the 10 patients with Grade III FCD. The extent of the cortical abnormality was larger on FDG-PET than on MRI in 11 (65%) of the 17 patients. CONCLUSION:FDG-PET is more useful in delineating the cortical abnormality in patients with mild degrees of FCD. The extent of the lesion was larger or similar on FDG-PET compared with that of the MRI.
Authors: Nadia Colombo; Laura Tassi; Carlo Galli; Alberto Citterio; Giorgio Lo Russo; Giuseppe Scialfa; Roberto Spreafico Journal: AJNR Am J Neuroradiol Date: 2003-04 Impact factor: 3.825
Authors: Chul-Kee Park; Seung-Ki Kim; Kyu-Chang Wang; Yong-Seung Hwang; Ki Joong Kim; Jong Hee Chae; Je G Chi; Ghee-Young Choe; Na Rae Kim; Byung-Kyu Cho Journal: Childs Nerv Syst Date: 2006-03-16 Impact factor: 1.475
Authors: Karolien Goffin; Wim Van Paesschen; Patrick Dupont; Kristof Baete; André Palmini; Johan Nuyts; Koen Van Laere Journal: Eur J Nucl Med Mol Imaging Date: 2010-03-20 Impact factor: 9.236
Authors: Nadia Colombo; Laura Tassi; Francesco Deleo; Alberto Citterio; Manuela Bramerio; Roberto Mai; Ivana Sartori; Francesco Cardinale; Giorgio Lo Russo; Roberto Spreafico Journal: Neuroradiology Date: 2012-06-14 Impact factor: 2.804
Authors: S Jayalakshmi; S K Nanda; S Vooturi; R Vadapalli; P Sudhakar; S Madigubba; M Panigrahi Journal: AJNR Am J Neuroradiol Date: 2019-04-18 Impact factor: 3.825
Authors: N Salamon; J Kung; S J Shaw; J Koo; S Koh; J Y Wu; J T Lerner; R Sankar; W D Shields; J Engel; I Fried; H Miyata; W H Yong; H V Vinters; G W Mathern Journal: Neurology Date: 2008-11-11 Impact factor: 9.910